We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

112 hedge funds and large institutions have $403M invested in BioDelivery Sciences International, Inc. in 2014 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

566% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $1.96M

178% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 9

38% more capital invested

Capital invested by funds: $293M → $403M (+$110M)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

17% more funds holding

Funds holding: 96112 (+16)

Holders
112
Holders Change
+16
Holders Change %
+16.67%
% of All Funds
3.22%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
25
Increased
44
Reduced
33
Closed
9
Calls
$13.1M
Puts
$1.96M
Net Calls
+$11.1M
Net Calls Change
+$14.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Manulife (Manufacturers Life Insurance)
76
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$330K +$33.9K +3,573 +15%
BA
77
BlackRock Advisors
Delaware
$306K -$16.7K -1,760 -6%
FPC
78
Falcon Point Capital
California
$287K -$135K -14,276 -37%
Nomura Holdings
79
Nomura Holdings
Japan
$283K +$227K +23,926 New
Wells Fargo
80
Wells Fargo
California
$275K +$195K +20,551 +934%
Deutsche Bank
81
Deutsche Bank
Germany
$274K +$42.1K +4,443 +24%
VOYA Investment Management
82
VOYA Investment Management
Georgia
$274K +$215K +22,707 New
ProShare Advisors
83
ProShare Advisors
Maryland
$246K -$164K -17,290 -46%
CCM
84
Condor Capital Management
New Jersey
$226K -$31.2K -3,287 -15%
TC
85
TFS Capital
Pennsylvania
$218K +$64.5K +6,801 +60%
CCMH
86
Cornerstone Capital Management Holdings
New York
$214K +$169K +17,800 New
NFG
87
Next Financial Group
Texas
$202K +$142K +15,000 New
FSA
88
Franklin Street Advisors
North Carolina
$199K +$156K +16,450 New
GC
89
Guggenheim Capital
Illinois
$195K -$24.7K -2,604 -14%
Fifth Third Bancorp
90
Fifth Third Bancorp
Ohio
$193K +$52.1K +5,500 +52%
Two Sigma Advisers
91
Two Sigma Advisers
New York
$170K +$134K +14,100 New
U
92
UBS
Switzerland
$166K +$74.7K +7,878 +134%
Principal Financial Group
93
Principal Financial Group
Iowa
$165K -$48.2K -5,085 -27%
Bank of America
94
Bank of America
North Carolina
$151K -$247K -26,089 -68%
SCM
95
Stevens Capital Management
Pennsylvania
$122K +$95.7K +10,089 New
SI
96
Stephens Inc
Arkansas
$121K
PCM
97
Prelude Capital Management
New York
$97K -$455K -48,000 -86%
QT
98
Quantbot Technologies
New York
$83K +$49.7K +5,240 +308%
Citigroup
99
Citigroup
New York
$51K -$35.3K -3,719 -47%
TDC
100
Thompson Davis & Co
Virginia
$47K +$13.3K +1,400 +56%

BDSI Hedge Fund Activity: Q2 2014 in Review

112 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2014, worth a combined $403M — up 38% from $293M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BDSI positions and 9 closed out — a net gain of 16 holders — while 44 added to existing stakes and 33 trimmed.

The largest buyer was Oak Ridge Investments, opening a new position worth an estimated $13.1M. The largest seller was Deerfield Management, cutting an estimated $25.2M.

  • 112 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2014, up from 96 in Q1 2014.
  • Funds reported $403M of BioDelivery Sciences International, Inc. stock for Q2 2014, up 38% quarter-over-quarter.
  • 25 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2014 and 9 closed out, a net change of +16 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2014 was Oak Ridge Investments, an estimated $13.1M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2014 was Deerfield Management, an estimated $25.2M sold.

Based on aggregated 13F filings for Q2 2014.